Haemonetics Corporation (HAE) News
Filter HAE News Items
HAE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HAE News Highlights
- HAE's 30 day story count now stands at 20.
- Over the past 8 days, the trend for HAE's stories per day has been choppy and unclear. It has oscillated between 2 and 4.
- BIO, CVS and HSIC are the most mentioned tickers in articles about HAE.
Latest HAE News From Around the Web
Below are the latest news stories about HAEMONETICS CORP that investors may wish to consider to help them evaluate HAE as an investment opportunity.
Here's Why You Should Invest in Insulet (PODD) Stock for NowInvestors are optimistic about Insulet (PODD), led by the strong adoption of Omnipod 5 and its strong solvency position. |
Here's Why You Should Retain Illumina (ILMN) Stock for NowInvestors are optimistic about Illumina's (ILMN) strength in the genomics market and strong solvency position. |
National Vision (EYE) Store Openings Aid, Macro Issues StayIn terms of store expansion, National Vision (EYE) continues to see sizable new opportunities for many years to come. |
Reasons to Buy Prestige Consumer (PBH) Stock for NowInvestors remain optimistic about Prestige Consumer (PBH), backed by the robust strength of its consumer brands portfolio. |
Align Technology (ALGN) Up 30% YTD: Will the Rally Continue?Investors are optimistic about Align Technology (ALGN), driven by recent strategic alliance and geographic expansion. |
Here's Why You Should Retain CVS Health (CVS) Stock for NowInvestors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan. |
Henry Schein (HSIC) Sales Hurt by Cyber Attack, Macro WoesHenry Schein's (HSIC) financial operations are being affected by the current macroeconomic environment. |
Orthofix (OFIX) Releases New Data for Spinal Fusion ProceduresAccording to Orthofix (OFIX), this data highlights the noninvasive and cost-effective nature of SpinalStim, enabling patients to continue their healing in the comfort of their homes. |
5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue their strong performance in 2024. |
Thermo Fisher (TMO) Unveils CorEvitas Pharmacovigilance PlatformThermo Fisher (TMO) introduces the CorEvitas pharmacovigilance platform for clinical research registries. |